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Structured Abstract 
Aim 
To assess the level of awareness and provision of screening and treatment for Diabetic Eye 
Disease (DED) comprising Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME) among 
health care professionals. 
Methods 
The study was conducted in two phases. The first phase consisted of a qualitative study, based 
on semi-structured face-to-face and telephone interviews in 8 countries.  The second phase 
used a quantitative approach utilising online surveys in 41 countries.  The survey for health care 
professionals comprised of 43 questions covering provider information, practice characteristics, 
management of adults with diabetes and specific information from ophthalmologists on 
screening and treatments for DR.  
Results 
There were 2,329 health care professionals who participated in the online survey.  More than 
one third of diabetes specialists surveyed reported that they did not discuss eye care with their 
diabetes patients.  Nearly two-thirds of all health care professionals surveyed reported that 
they had written information about diabetes for patients available in their practice.  Only one in 
five (22%, n=58) primary care providers reported they had material that contained sufficient 
information on eye complications, and 37% (n=252) of ophthalmologists reported that they had 
sufficient information on eye complications. 
Sixty-five percent (n=378) of ophthalmologists reported that most of their patients presented 
when visual problems had already occurred.  Six percent (n=36) stated that most of their 
patients presented when it was already too late for effective treatment. 
The most substantial barriers to eye health mentioned by health care professionals responding 
to the survey were: a patients’ lack of knowledge and/or awareness about eye complications 
(43%), followed by lack of importance given to eye examinations by patients (33%), and the 
high cost of care (32%).  Ophthalmologists also reported late screening (66%), and lack of 
patient education materials (55%) as obstacles for improving eye health outcomes. 
Conclusion 
Health care professionals need to be appropriately supported and trained so they can provide 
adults with diabetes with information about the risks of DR, support them in reducing their risk, 
and advocate for the provision of affordable DR screening and treatment as required. 
  
 
 
1. Introduction 
An estimated 425 million people (aged 20-79 years) are currently living with diabetes globally, 
of whom half (50%) remain undiagnosed[1].  Consequently, when diagnosed, many people with 
diabetes have already developed complications arising from their condition. One of the most 
common complications of diabetes is diabetic eye disease (DED)[2] comprising of several 
conditions including diabetic macular edema (DME), diabetic retinopathy (DR), cataract and 
glaucoma. If not treated early and correctly, DED can progress to cause visual impairment and 
blindness[3][4].  
Diabetic retinopathy occurs when blood vessels in the light-sensitive region of the eye, the 
retina, leak or become blocked, due to prolonged high blood glucose levels[3].  DR is the most 
common cause of vision loss in people with diabetes [5][6] and globally is the leading cause of 
visual impairment and blindness among working age population[7][8].  A common complication 
of DR is DME, where leakage from retinal blood vessels builds up in the central region of the 
retina, the macula, causing it to swell[5].  DME can be associated with any severity of DR, and as 
the macula is responsible for detailed central vision, it can lead to rapid vision loss if not 
detected and treated promptly.  However, DR can be prevented or delayed by timely diagnosis 
and management of diabetes, and blindness can be prevented or delayed in people with DR by 
regular eye screening and appropriate treatment[9].   
Despite the high risk of people with diabetes developing DED, many suffer from limited access 
to appropriate screening and treatment. In some countries, this is partly due to a lack of 
appropriately-trained health care professionals.  To address this, the International Federation 
on Ageing (IFA), in collaboration with the International Diabetes Federation (IDF), and the 
International Agency for the Prevention of Blindness (IAPB) conducted a multi-country research 
study, called the DR Barometer.  This research project examined risk awareness, access to DR 
screening and treatment, the nature of health services and community support available, and 
the socioeconomic consequences of DR and DME.   
In this paper, the detailed findings on the provision of DR screening and treatment from the 
perspective of health care professionals are presented.  
 
2. Methods  
The DR Barometer Study constituted of two phases.  Phase 1 utilised qualitative methods, and 
phase 2 employed quantitative methods.  In both phases, adults with diabetes (patients) and 
health care professionals (providers) were invited to join the study and analysed through 
separate surveys. 
In phase 1, the surveys for adults with diabetes and health care professionals were developed 
following the completion of semi-structured interviews in eight countries: Argentina, 
Bangladesh, Germany, Japan, Mexico, Romania, Saudi Arabia and Uganda.  The countries were 
purposively selected to reflect World Bank Income Groups [10] and regions as defined by the 
World Health Organization (WHO) [11].   
  
 
 
Details of the interview structure, delivery and analysis have been described previously [12].  
The data from the interviews were used to inform the development of the surveys in the 
quantitative study (Phase II).  Data from the survey for adults with diabetes have been 
published separately [13].   
The survey for health care professionals comprised 43 questions covering provider information, 
practice characteristics, management of adults with diabetes and specific information from 
ophthalmologists on screening and treatments for DR.  The full questionnaire is available online 
[12]. 
Similar to the interviews, the survey was aimed to be implemented in a globally diverse set of 
41 countries, covering all WHO regions [11] and World Bank Income Groups [10] (see table 1). 
Surveys were developed in English and then translated into the respective language of each 
country, before being back-translated to ensure veracity of the translations.  National member 
organisations of the partners (IFA, IAPB and IDF), professionals from hospitals, diabetes centres, 
and clinicians in each of the countries selected were then invited to disseminate the surveys 
amongst adults with diabetes, older people and health care professionals.  The study 
populations were therefore self-selected samples of adults with diabetes and health care 
professionals, who accessed the survey predominantly from professional or patient and seniors 
organisations concerned with diabetes or eye health, as well as from membership organisations 
of older adults.  All responses were anonymous, and the survey was open and available for 
completion for a period of 9 months in 2015. 
Evaluation and analysis of survey data has been previously described [13].  Briefly, data were 
cleaned with removal of implausible data values and of duplicate records.  Continuous data 
were summarised using mean, standard deviation, minimum, median and maximum and 
categorical data were summarised using frequency counts and percentages.  All analyses were 
performed using SAS version 9.4 [14].  
For presentation of data on DED, the following definitions were used: no DED was defined as 
‘without diabetic eye disease’; DED was defined as ‘with diabetic eye disease’ AND ‘without 
diabetic macular edema (DME); and DME was defined as ‘diabetic eye disease’ AND ‘diabetic 
macular edema’. 
 
3. Results  
Interviewee characteristics 
In total, 48 healthcare providers were interviewed and each region was equally represented. 
(Table 1) Both Northern and Southern part of Americas as well as Eastern and Western part of 
Europe had six interviews. Twenty-nine percent of respondents were primary care providers, 
13% diabetes educators, 17% endocrinologists or diabetes specialists, 19% ophthalmologists, 
and 19% retinal specialists. The majority (79%) worked in urban settings. 
Survey respondent characteristics 
There were 2,329 health care professionals (providers) who responded to the survey. (Table 1) 
Based on WHO’s regions, 45% (n=1048) were from the European Region, 23% (n=536) from the 
  
 
 
Region of the Americas and 16% (n=382) from the Western Pacific Region, with the remaining 
16% (n=363) from the three other regions (African Region, South-East Asia Region, Eastern 
Mediterranean Region).  Based on World Bank income classification, fifty-two percent of 
respondents (n=1216) were from high-income countries and 45% (n=1043) were from upper-
middle-income countries. 
Regarding their professional expertise, thirty-seven percent of respondents (n=855) were 
ophthalmologists, 17% (n=403) were medical doctors specialising in diabetes, and 16% (n=365) 
were primary care providers.  The rest were optometrists, nurses, health educators or other 
types of health care professionals.  The ophthalmologists included general ophthalmologists 
and retinal specialists.  There was a similar proportion of ophthalmologists in high-income 
countries (36%, n=441) and upper-middle-income countries (38%, n=397). 
The majority of health care professionals (89%, n=1924) had their main practices in urban 
settings.  Forty-seven percent (n=1019) practiced in the governmental sector whilst almost a 
third (29%, n=633) had their main practice in the private sector, 15% (n=331) worked in a 
combined or mixed sector and 8% (n=172) in the non-profit sector.  
Ophthalmologists had their main practice setting in hospitals (49%, n=396) or eye clinics (46%, 
n=376) whereas diabetes specialists practiced primarily in diabetes clinics (45%, n=175) or 
hospitals (37%, n=144).  The majority of primary care providers were in general medical 
practice (72%, n=239) and a further 13% (n=44) in hospitals. 
Table 1. Characteristics of participants in both phases of the study 
Characteristic Interviews Questionnaires 
All 48 2,329 
Region 
    Europe 
    Americas 
    Western Pacific 
    Eastern Mediterranean 
    Africa 
    South East Asia 
 
25% (n=12) 
25% (n=12) 
13% (n=6) 
13% (n=6) 
13% (n=6) 
13% (n=6) 
 
50% (n=2163) 
23% (n=536) 
16% (n=382) 
11% (n=246 
4% (n=85) 
1% (n=32) 
Gender 
    Female 
    Male 
 
46% (n=22) 
54% (n=26) 
 
- 
- 
Age 
    18-39 
    40-59 
    60-74 
    75+ 
 
15% (n=7) 
71% (n=34) 
15% (n=7) 
0% (n=0) 
 
- 
- 
- 
- 
Residence  
    Rural 
    Urban 
 
21% (n=10) 
79% (n=38) 
 
11% (n=405) 
89% (n=1924) 
Specialty 
    Primary care provider 
    Endocrinologist 
 
29% (n=14) 
17% (n=8) 
 
16% (n=365) 
17% (n=403) 
  
 
 
    Eye Care Professional 
    Other (including nurse or 
diabetes educator) 
38% (n=18) 
13% (n=6) 
 
37% (n=855) 
30% (n=706) 
 
Providing information to adults with diabetes 
During routine visits, the topics most commonly discussed with adults with diabetes were: 
diabetes management and monitoring, eye care and exams, medicines and nutrition.  Only 47% 
(n=127) of primary care providers and 62% (n=189) of diabetes specialists discussed eye care 
and examinations with their patients.  In contrast, 94% (n=634) of ophthalmologists routinely 
discussed the topic yet many fewer discussed other issues such as diabetes management or 
blood pressure (Table 2).  
Table 2. Heath care topics discussed with patients during a routine visit 
 
Topic 
All Providers 
n (%) 
(n=2,329) 
Primary care 
n (%) 
(n=365) 
Diabetes 
specialist 
n (%) 
(n=403) 
Ophthalmologist  
n (%) 
(n=855) 
Diabetes 
management and 
monitoring 
1,326 (77.7%) 253 (94.4%) 284 (93.7%) 410 (60.5%) 
Diet/nutrition 1,083 (63.4%) 237 (88.4%) 278 (91.7%) 241 (35.5%) 
Exercise/physical 
activity 
1,042 (61.0%) 232 (86.6%) 266 (87.8%) 222 (32.7%) 
Medicines 1,210 (70.9%) 254 (94.8%) 288 (95.0%) 310 (45.7%) 
Foot care and 
inspection 
701 (41.1%) 175 (65.3%) 239 (78.9%) 50 (7.4%) 
Blood pressure 1,071 (62.7%) 244 (91.0%) 280 (92.4%) 244 (36.0%) 
Eye care and exams 1,249 (73.2%) 127 (47.4%) 189 (62.4%) 
634 (93.5%) 
Lipid check 835 (48.9%) 214 (79.9%) 253 (83.5%) 151 (22.3%) 
Other 13 (0.8%) 1 (0.4%) 7 (2.3%) 1 (0.1%) 
None of the above 31 (1.8%) 4 (1.5%) 2 (0.7%) 13 (1.9%) 
Total valid response 1,707 (100.0%) 268 (100.0%) 303 (100.0%) 
678 (100.0%) 
Total missing 622 97 100 177 
NB [1]: There were some missing data (not all respondents provided responses to every question). Percentages for the first row and column are ca lculated using the 
total number of respondents minus the number of missing values as the denominator. All other percentages are calculated using the total on the corresponding ro w 
of the first column as the denominator. 
NB [2]: The group with DED excludes all adults with DME 
  
 
 
Whereas nearly two-thirds (64%, n=1,089) of all providers had written information available 
about diabetes for patients in their main practice, only a third (34%, n=573) reported that the 
information on eye complications was sufficient.  The nature of information available at these 
practices varied with the type of the provider.  Only one in five (22%, n=58) primary care 
providers had material that contained sufficient information on eye complications, and 37% 
(n=252) of ophthalmologists had sufficient information on eye complications.  Furthermore, 
15% (n=102) of ophthalmologists had insufficient information on eye complications and 38% 
(n=258) did not have any written information available.   
Screening for DR 
Most health care professionals surveyed (73%, n=1,272) screened patients for DR. Screening 
occurred mainly in the clinic (79%, n=953) but also via outreach clinics and mobile vans (15%, 
n=177).  These examinations were most frequently performed by ophthalmologists, who used a 
range of procedures including fundoscopy (99%, n=697), optical coherence tomography (89%, 
n=608), and angiography (86%, n=567).  
Eye examinations were also performed by primary care providers and diabetes specialists, with 
fundoscopy performed by 42% (n=109) of primary health providers and 58% (n=181) of 
diabetes specialists.  Angiography was performed by 15% (n=37) of primary care providers and 
27% (n=81) of diabetes specialists. 
For adults with type 1 diabetes, the majority of providers (51%, n=827) said that they would 
perform an initial eye exam as soon as the patient was diagnosed, while 21% (n=345) did so 
after a pre-determined number of years, and 14% (n=222) of providers said the timing varied 
on a case by case basis. 
This approach was generally consistent amongst the different types of providers.  For people 
with type 2 diabetes, 77% (n=1274) of providers said that they would perform an initial eye 
exam as soon as the patient was diagnosed, this percentage was even higher among diabetes 
specialists (87%, n=257).  Eleven percent (n=177) of all providers reported that the timing 
varied on a case by case basis.   
Seventy-six percent of providers (n=1,261) reported that their protocol for follow-up eye 
examinations for adults with diabetes was once per year.  However, the timing varied amongst 
all providers with 69% (n=178) of primary care providers having yearly follow-up exams 
compared with 86% (n=254) of diabetes specialists. 
Written protocols for the detection and management of diabetes-related vision issues were 
available in 53% (n=900) of the main practices of all providers but in 9% (n=157) of these 
practices, the protocols were not used by staff.  Forty percent (n=107) of primary care providers 
reported that there were no written protocols available and a further 13% (n=34) had protocols 
but these were not used by staff.  Thirty-nine percent of diabetes specialists and 49% (n=328) of 
ophthalmologists had protocols that were used by staff (see Table 3).   
 
Table 3. Written protocols for the management of diabetes-related vision issues. 
  
 
 
Response 
All Health care 
professionals 
n (%) 
(n=2,329) 
Primary Care 
n (%) 
(n=365) 
Diabetes 
Specialist 
n (%) 
(n=403) 
Ophthalmologist 
n (%) 
(n=855) 
Yes, available and 
used by staff 
743 (44%) 94 (35.6%) 115 (38.6%) 328 (48.8%) 
Yes, available but 
not used by staff 
157 (9.3%) 34 (12.9%) 34 (11.4%) 66 (9.8%) 
Not available 596 (35.3%) 107 (40.5%) 131 (44.0%) 222 (33.0%) 
Don't know/Not 
sure 
191 (11.3%) 29 (11.0%) 18 (6.0%) 56 (8.3%) 
Total valid 
response 
1,687 (100.0%) 264 (100.0%) 298 (100.0%) 672 (100.0%) 
Total missing 642 101 105 183 
NB [1]: The values [n=xx] show the maximum number of respondents in that group, but percentages are calculated from non-missing values for 
that group for the specific question 
 
Treatment 
Multiple treatments were available in the practices of ophthalmologists. Laser 
photocoagulation was offered in 80% (n=495) of practices, anti-VEGF therapies in 77% (n=476) 
of practices, intravitreal steroid in 74% (n=450), uncomplicated vitrectomy in 64% (n=389) and 
complex vitreo-retinal surgery in 61% (n=373).  Most ophthalmologists (84%, n=507)) personally 
administered treatment for DR.   
The lack of access to treatments in low- and middle- income countries was highlighted in the in-
depth interviews during the first phase of the study.  For example, a diabetes educator in 
Argentina reported that only two of the 20 ophthalmologists in Buenos Aires were able to treat 
DR.  Apart from the lack of trained personnel, the high cost of medications and equipment 
limited access to treatments.  An ophthalmologist in Uganda reported that there was 
insufficient equipment to provide laser treatment to those that need it.  
More than half of ophthalmologists reported that diabetes duration, high glucose levels and the 
presence of co-morbidities influenced the treatment decisions of adults diagnosed with DR and 
DME.  The age of the patient and adherence to recommendations were factors that influenced 
the nature of treatments and care management (Figure 1). 
Figure 1. Patient characteristics that influence treatment decisions 
  
 
 
 
NB [1]: The values [n=xx] show the maximum number of respondents in that group, but percentages are calculated from non-missing values for 
that group for the specific question 
 
Training 
The level of relevant experience and training on DED, including DME, among health care 
professionals varied.  On average, providers had been practicing for 16 years and most had 
completed graduate or advanced degree education (72%, n=1,154).  Twenty-one percent 
(n=122) of ophthalmologists had received no specific training on the diagnosis or treatment of 
DR and / or clinically significant DME.  Of the 79% who had received training, half had done so 
within the past year (55%, n=256), while 18% (n=84) received training more than five years ago.  
Three quarters of ophthalmologists (77%, n=455) expressed interest in further education and 
certification on the management of DR.  
The qualitative study highlighted the impact that a lack of knowledge amongst providers could 
have on the care of adults with diabetes.  Findings suggest that while health care professionals 
knew of the risk of DR in people with diabetes, they did not always recognise the importance of 
retinal examinationsl.  
First of all, they do not know how to send patients, or they do not recommend that the 
patient goes to a specialist. Unfortunately, the diabetologists and sometimes even our 
ophthalmology colleagues are happy just to prescribe glasses, without examining the 
optic fundus. (Ophthalmologist, Romania) 
Barriers to optimal eye health 
From the provider perspective, the major barrier to optimising eye health faced by adults with 
diabetes was a lack of knowledge and / or awareness about the potential effect of diabetes on 
their eyes.  Overall, 43% (n=732) of providers reported this as a barrier, including 51% (n=347) 
of ophthalmologists.  Furthermore, 65% (n=378) of ophthalmologists reported that most of 
their patients presented when visual problems had already occurred.  Six percent (n=36) stated 
that most of their patients presented when it was already too late for effective treatment.  Only 
29% (n=169) said that most patients presented in time for screening.   
0% 10% 20% 30% 40% 50% 60% 70% 
High glucose levels 
Presence of comorbidities such as hypertension, etc. 
Diabetes duration 
Patient adherence to recommendations 
Patient's age 
Total missing 
Patient educational level 
Ability or inability to pay 
Insurance restrictions 
None of the above 
Patient's gender 
Not applicable 
  
 
 
In interviews conducted in the qualitative study, primary care providers and diabetes specialists 
felt that many of their patients with diabetes did not appreciate the importance of eye 
screening and were not motivated to visit an eye doctor if they did not have symptoms of vision 
impairment.  They reported that their patients did not understand that a person may have 
asymptomatic DR and that early treatment reduces the risk of vision loss. 
Those who were referred, they do not come until they are not able to see. Otherwise, 
they say that I was told five years ago, but I could see, so I did not come. They wait for 
vision problems, then come. For DR that is too late. (Ophthalmologist, Uganda) 
Other barriers to optimising eye health included: adults with diabetes feeling that eye 
examinations were not important; the high cost of care; long wait times for an appointment; 
patients feeling eye complications were unlikely to happen; patients’ fear of treatment or its 
results; limited access to eye specialists; and the complex referral process (Table 4).   
The qualitative study reinforced the finding that cost was a barrier to eye health.  In each of the 
eight countries, some out of pocket payments were required for insurance premiums, to see 
particular providers and to access certain therapies.   These costs impacted the availability of 
treatment for DR, particularly in middle- and low-income countries, where institutional 
resources are scarce and people with diabetes may be struggling just to meet basic needs. In 
some cases, providers reported that they offered services at a subsidised price to make 
treatments accessible to those who could not otherwise afford them.   
In the quantitative study, sixty percent of providers (n=1141) reported that their patients wait 
less than one month for an appointment but 15% (n=282) reported a waiting time of more than 
two months.  The waiting time varied considerably amongst the types of providers.  Fifty-three 
percent of primary care providers (n=153) reported a waiting time of less than one week, 
compared with only 20% of ophthalmologists (n=150).   
Inadequate referral processes were a strong theme in the interviews, with reports of some 
hospital ophthalmology departments not accepting referrals from diabetes specialists from the 
same hospital: 
They must be sent from a family medicine clinic.  So, for example, when I see a patient 
with diabetic retinopathy, I have to send them once again to see his family doctor, so he 
can be sent to the ophthalmologist from there.  (Diabetes specialist, Mexico) 
The interviews also highlighted the difficulty of communication between disciplines as well as 
between the patient and health care professional.  Some providers relied on their patients to 
convey medical information by specifically asking them to bring written reports from other 
medical specialists.  Others more casually asked about care received, as illustrated by a primary 
care provider in Germany who sometimes had to ask the patient about the outcome of a visit to 
the eye specialist, from whom they often received no information. 
“What can be a problem sometimes, depending on where we send them, like eye 
specialists, we get more or less feedback...there are standardised forms that [aren’t] 
much trouble and that we get from a lot of eye specialist practices, but not always. 
Then you have to ask the patients themselves if he has been to the eye specialist and 
  
 
 
then the statement is not always very correct and reliable. This can be a problem then 
... you don’t exactly know if the patient has a problem or not.” (Primary care provider, 
Germany)  
 
The most substantial barrier reported by all health care professionals was the lack of knowledge 
and/or awareness of patients about diabetic eye complications (43%, n=732), followed by the 
lack of importance patients gave  to eye examinations  (33%, n=561), and the costs associated 
with care (32%, n=552).  For primary care providers, long waiting times for scheduling an 
appointment was among the most commonly reported barriers (Table 4).   
 
Table 4. Barriers reported by health care professionals to optimising eye health. 
Barrier 
All health care 
professionals 
Primary Care 
Providers 
(N=365) 
Diabetes 
Specialists 
(N=403) 
Ophthalmologists 
(N=855) 
Lack of knowledge and/or awareness 732 (42.9%) 99 (36.3%) 100 (33.0) 347 (51.2%) 
Patients feel eye exams are not 
important 
561 (32.9%) 79 (29.5%) 76 (25.1%) 243 (35.8%) 
Cost of care 552 (32.3%) 73 (27.2%) 100 (33.0%) 255 (37.6%) 
Long wait time for appointment 525 (30.8%) 117 (43.7%) 107 (35.3%) 186 (27.4%) 
Patients feel eye complications are 
unlikely 
510 (29.9%) 61 (22.8%) 70 (23.1%) 245 (36.1%) 
Patients fear of treatment/results 467 (27.4%) 60 (22.4%) 77 (25.4%) 218 (32.2%) 
Limited access to eye specialists 452 (26.5%) 102 (38.1%) 89 (29.4%) 148 (21.8%) 
Referral process 446 (26.1%) 93 (34.7%) 64 (21.1%) 200 (29.5%) 
Patients have competing 
responsibilities and priorities 
389 (22.8%) 43 (16.0%) 61 (20.1%) 166 (24.5%) 
Proximity to care 369 (21.6%) 58 (21.6%) 54 (17.8%) 167 (24.6%) 
Limited access to diabetes specialists 332 (19.4%) 71 (26.5%) 31 (10.2%) 138 (20.4%) 
Long wait time on the day of visit 272 (15.9%) 42 (15.7%) 53 (17.5%) 112 (16.5%) 
Clinic too small or lack necessary 
equipment/staff 
178 (10.4%) 37 (13.8%) 39 (12.9%) 56 (8.3%) 
  
 
 
Patients they are a burden on 
family/friends 
162 (9.5%) 24 (9.0%) 13 (4.3%) 79 (11.7%) 
Recommended treatments are not 
available 
148 (8.7%) 33 (12.3%) 31 (10.2%) 55 (8.1%) 
Other 103 (6.0%) 16 (6.0%) 16 (5.3%) 31 (4.6%) 
Total valid response 1,707 (100.0%) 268 (100.0%) 303 (100.0%) 678 (100.0%) 
Total missing 622 97 100 177 
NB [1]: The values [n=xx] show the maximum number of respondents in that group, but percentages are calculated from non-missing values for 
that group for the specific question 
 
With respect to the ophthalmologists’ views on the barriers to improving outcomes of patients 
with DED, 66% (n=373) mentioned late diagnosis; 55% (n=310) felt mentioned poor access to 
patient education on DR and 39% (n=220) mentioned poor multi-disciplinary team integration, 
referral pathways and reimbursement restrictions.  Only 7% (n=38) of ophthalmologists 
reported that current therapies were not effective (Figure 2).    
Figure 2. Barriers to improving patient outcomes with DED as reported by health care 
professionals   
 
 
 
4. Discussion 
The DR Barometer study captured for the first time the views and experiences of over 2,300 
health care professionals from 41 countries involved in the management of adults with 
diabetes and subsequent eye health conditions, including DR and DME.  
0% 10% 20% 30% 40% 50% 60% 70% 
Late diagnosis 
Limited access to patient education on DR and DME 
Referral pathways 
Multi-disciplinary team integration is poor 
Reimbursement/restrictions on approved therapy 
Government/insurance not able to cover patient costs 
Ineffective screening services 
No universal guidelines on referral/screening 
No universal guidelines on how to treat 
No universal guidelines on when to treat 
Current available therapies not effective 
Other 
  
 
 
Findings from the DR Barometer study illustrate how by their own admission, primary care 
providers and diabetes specialists did not discuss eye care and the need for regular 
examinations with patients, with the regularity needed.  Previous data already published from 
the study confirmed this observation from the viewpoint of people with diabetes, many of 
whom were unaware that diabetes could affect their eyes [14].  While almost all 
ophthalmologists routinely discussed eye health, only around a third discussed diabetes 
management in general, or blood pressure control in particular, even though this directly 
impacts progression of DR. 
It is well established that many people have difficulty recalling the details of medical 
consultations [18]. Therefore, written information can be very useful in conveying important 
messages.  Yet only a third of health care professionals surveyed had sufficient written 
information on DR available in their clinic.  
It is therefore hardly surprising that providers reported a lack of awareness of DR amongst 
adults with diabetes as the most commonly reported barrier to optimising eye health and that 
nearly two-thirds of ophthalmologists reported that most patients presented when visual 
problems had already occurred and sometimes when it was already too late for effective 
treatment.  Other major barriers included the high costs and waiting times for screening and 
treatment. 
Health care professionals were also lacking in protocols to guide their own practice, with less 
than half having written protocols for the detection and management of diabetes-related vision 
issues.  The lack of protocols may explain the variations in the factors that influenced 
ophthalmologists’ treatment decisions, which included age, gender and educational level.  
Furthermore, the observation that more than one in five ophthalmologists reported that they 
had no formal training in the diagnosis or management of DR is a cause for concern. 
Effective management of diabetes often requires people with diabetes to visit a number of 
specialists.  Good communication, efficient referral practices, and a clear patient care pathway 
are essential to ensure that each professional has the appropriate patient information.  
However, this study suggests that suboptimal communication and referral practices between 
specialists were hindering effective care.   
The rise in aging populations is likely to place excessive and unrelenting demands on the eye 
health and diabetes sectors in many countries, potentially leaving individuals with diabetes 
without timely access to screening and appropriate treatment that could help preserve their 
vision and function ability, and thereby their contribution to family and society.  It is thus 
essential that all stakeholders involved in the management of adults with diabetes are in a 
position to implement practices to provide education on prevention, screen for and treat DED.    
The most clinically and cost-effective response to the threat of DR is firstly to prevent diabetes 
from occurring [16], and secondly to prevent the onset of complications and its progression to a 
sight-threatening stage [17][18].  This is best achieved by preventing the onset of type 2 
diabetes, supporting people with both type 1 and type 2 diabetes to keep their condition as 
well controlled as possible, and educating people with diabetes about the risks of DED and of 
the importance of regular eye screening.   
  
 
 
Limitations 
Although the study had a large sample size, it may not be representative of the broader 
population of these constituents. Different results might have been reached with a larger 
number of participants from low- and middle-income countries. The study population was self-
selected and largely recruited through patient and civil society organisations and the practices 
of health care professionals, so participants were more likely to be interested in and engaged in 
the care of diabetes and DED than other providers.  Consequently, their experiences may differ 
from a general sample of health professionals. 
The consistency with which information was collected varied between respondents resulting in 
missing data and implausible responses to some questions. The variation in the consistency of 
the information collected may reflect different levels of understanding of the terminology and 
cultural differences in language used within the survey.  
In most analyses, missing data were excluded with the underlying assumption that the 
observed data provided a reasonable representation of the study population and that the 
results would be consistent regardless of missing data. The reasons for missing data were 
unknown and therefore not clear as to whether bias was introduced into the analysis as a 
result. However, where bias does exist, the impact is likely to be greatest in analyses involving a 
small number of observations.  
For some questions, respondents were able to select multiple answers. Whilst this provided 
broader insights from patients and providers, it also poses a challenge when interpreting the 
results as the total number of responses for some questions is greater than the total sample 
size. 
 
Conclusion 
In summary, in rising to the challenge of increasing prevalence of DR,  Health care professionals 
need to be appropriately supported and trained so that they can work together to ensure that 
all adults with diabetes are well informed about the risks of DR, are supported in reducing their 
risk and have access to DR screening and appropriate treatment as required. 
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